HCA Healthcare, Inc. (HCA) Stock

About HCA Healthcare, Inc.

HCA Healthcare, Inc. is led by CEO Samuel N. Hazen, employs 320,000 people, headquartered in Nashville, US, publicly traded since 2011.

HCA Healthcare, Inc. (HCA) stock trades at $451.09 with a market capitalization of $97.66B. The stock is valued at a price-to-earnings (P/E) ratio of 14.57, price-to-book of -14.79, price-to-sales of 1.21. Over the past 52 weeks the stock has ranged between $353.99 and $556.52, and currently trades 18.9% below its 52-week high. It pays a dividend yielding 0.72%.

On profitability, HCA Healthcare, Inc. generates a return on equity (ROE) of -112.87%, return on capital employed of 29.17%, an operating margin of 15.83%, a net profit margin of 8.77%.

In its most recent fiscal year, HCA Healthcare, Inc. reported annual revenue of $75.6B, net profit of $6.8B, revenue has compounded at 8.0% a year over the last five years, profit at 12.6% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of -7.42 — a conservative balance sheet with little leverage risk, a current ratio of 0.83, total assets of $60.7B, $1.0B in cash and equivalents.

HCA has a beta of 1.11.